Watchlist Price Alert

Nektar Therapeutics (NKTR)

NASDAQ: NKTR · Real-Time Price · USD

8.56

-0.20 (-2.28%)

At close: Jun 13, 2025, 3:59 PM

8.70

1.58%

After-hours: Jun 13, 2025, 07:18 PM EDT

Nektar Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	44.25M	35.28M	88.23M	25.22M	198.96M	96.36M	194.91M	4.76M	59.64M
Short-Term Investments	210.97M	268.34M	416.75M	708.74M	862.94M	1.23B	1.14B	291.37M	329.46M
Long-Term Investments	26.09M	25.82M	n/a	64.83M	136.66M	279.12M	582.89M	57.09M	n/a
Other Long-Term Assets	4.65M	4.64M	2.25M	2.74M	1.46M	1.01M	4.24M	994K	517K
Receivables	1.61M	2.25M	5.98M	22.49M	38.89M	36.8M	43.21M	5.01M	15.68M
Inventory	n/a	16.1M	19.2M	15.8M	15.29M	12.66M	11.38M	10.73M	11.11M
Other Current Assets	n/a	n/a	15.81M	23.33M	n/a	47.22M	21.29M	14.35M	10.36M
Total Current Assets	261.29M	330.7M	545.97M	795.58M	1.14B	1.42B	1.44B	326.82M	426.25M
Property-Plant & Equipment	11.82M	36.86M	85.89M	177.53M	186.14M	199.18M	48.85M	47.46M	65.6M
Goodwill & Intangibles	n/a	n/a	76.5M	76.5M	76.5M	76.5M	76.5M	76.5M	76.5M
Total Long-Term Assets	42.56M	67.33M	164.63M	321.61M	400.76M	555.81M	712.49M	182.05M	142.62M
Total Assets	303.85M	398.03M	710.6M	1.12B	1.54B	1.98B	2.15B	508.87M	568.87M
Account Payables	11.56M	9.85M	12.98M	9.75M	22.14M	19.23M	5.85M	4.78M	2.82M
Deferred Revenue	n/a	n/a	n/a	n/a	91K	5.52M	13.89M	18.95M	14.35M
Short-Term Debt	19.87M	n/a	18.67M	17.44M	13.91M	261.21M	n/a	n/a	2.91M
Other Current Liabilities	29.97M	16.61M	8.31M	24.84M	51.19M	56.47M	52.32M	24.17M	32.37M
Total Current Liabilities	61.4M	51.27M	68.2M	85.2M	115.78M	353.89M	82M	56.16M	72.22M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	46.98M	246.95M	245.21M	243.46M
Other Long-Term Liabilities	99.02M	117.26M	162.93M	226.75M	206.86M	25.81M	92.9M	100.65M	110.95M
Total Long-Term Liabilities	181.71M	215.78M	275.76M	352.48M	345.69M	218.07M	350.6M	364.88M	408.52M
Total Liabilities	243.11M	267.05M	343.96M	437.68M	461.47M	571.97M	432.6M	421.04M	480.75M
Total Debt	102.56M	117.78M	131.5M	143.18M	150.29M	403.94M	246.95M	245.21M	248.59M
Common Stock	19K	19K	19K	19K	18K	17K	17K	15K	15K
Retained Earnings	-3.6B	-3.48B	-3.2B	-2.83B	-2.31B	-1.86B	-1.42B	-2.12B	-2.02B
Comprehensive Income	61K	80K	-6.91M	-4.16M	-2.29M	-1M	-6.32M	-2.11M	-2.36M
Shareholders Equity	60.74M	130.99M	366.64M	679.51M	1.08B	1.41B	1.72B	87.83M	88.13M
Total Investments	237.06M	294.16M	416.75M	773.57M	999.6M	1.51B	1.72B	348.46M	329.46M